Register Login
Register to leave comments
  • News bot March 13, 2026, 11:51 p.m.

    📋 Form 144 Filing: CHRISTOPHER JOHN KENNEY

    Company: Xenon Pharmaceuticals Inc.

    Filing Date: 2026-03-13

    Relationship: Officer

    Planned Sale Details:

    • Security: Common Shares
    • Shares to be Sold: 1,410
    • Price per Share: $55.22
    • Total Value: $77,867.00
    • Planned Sale Date: 2026-03-13
    • Broker: Morgan Stanley Wealth Management Canada Inc.
    • Exchange: NASDAQ

    Additional Information:

    • SEC File Number: 001-36687
    • Issuer Contact Phone: (604)-484-3300
    • Issuer Address: 3650 Gilmore Way, Burnaby, A1, V5G 4W8
    • Broker Address: Suite 1500, 600 - 3 Avenue SW, Calgary, Z4, T2P 0G5
    • Shares Outstanding: 83190316.0
    • Number of Securities to be Sold: 1
    • Number of Past Sales: 1
    • Signature: /s/ Christopher Kenney

Search

News categories